Abstract
Stereoisomers are molecules that are identical in atomic constitution and bonding. The biological properties may, however, differ significantly between two enantiomers (individual stereoisomers). JBC 1847, a phenothiazine derivative with strong antimicrobial activity against Gram-positive bacteria, exists in two enantiomers, S and R. Under standard chemical synthesis (S)-and (R)-JBC 1847 will be present in 50/50 amount (racemic). In this study, we have investigated the antimicrobial activity, the in vivo tolerance and therapeutic efficacy of purified (S)-JBC 1847. Compared to JBC 1847 racemic, the antimicrobial activity of (S)-JBC 1847 in vitro was in the same range or slightly increased, while the maximum tolerable concentration in vivo was five times higher for (S)-JBC 1847 (5 mg/kg versus 20 mg/kg bodyweight). Furthermore, the in vivo efficacy of (S)-JBC 1847 in a mouse peritonitis MRSA model was comparable to the activity of vancomycin. In conclusion, the antimicrobial activity and tolerance of a medical stereoisomeric compound may be significantly different using purified enantiomers compared with the racemic state.
Original language | English |
---|---|
Journal | Indian Journal of Microbiology |
Volume | 64 |
Issue number | 2 |
Pages (from-to) | 743–748 |
Number of pages | 6 |
ISSN | 0046-8991 |
DOIs | |
Publication status | Published - 2024 |
Bibliographical note
Publisher Copyright:© The Author(s) 2024.
Keywords
- Antimicrobial activity
- In vivo models
- MRSA
- Phenothiazine derivatives
- Stereoisomers
- Toxicity